WELL Health Technologies Corp
WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. The company offers omni-channel patient services and solutions to specific markets, such as medical recruitment and staffing, anesthesia, gastrointestinal health, women's health, primary care, and behavioural health. It also develops, integrates, and sell… Read more
WELL Health Technologies Corp (WELL) - Net Assets
Latest net assets as of September 2025: CA$844.39 Million CAD
Based on the latest financial reports, WELL Health Technologies Corp (WELL) has net assets worth CA$844.39 Million CAD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$2.02 Billion) and total liabilities (CA$1.17 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CA$844.39 Million |
| % of Total Assets | 41.82% |
| Annual Growth Rate | 92.74% |
| 5-Year Change | 324.58% |
| 10-Year Change | 260530.47% |
| Growth Volatility | 196.21 |
WELL Health Technologies Corp - Net Assets Trend (2011–2024)
This chart illustrates how WELL Health Technologies Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for WELL Health Technologies Corp (2011–2024)
The table below shows the annual net assets of WELL Health Technologies Corp from 2011 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CA$929.72 Million | +9.88% |
| 2023-12-31 | CA$846.15 Million | +3.79% |
| 2022-12-31 | CA$815.25 Million | +15.14% |
| 2021-12-31 | CA$708.05 Million | +223.35% |
| 2020-12-31 | CA$218.98 Million | +584.25% |
| 2019-12-31 | CA$32.00 Million | +215.43% |
| 2018-12-31 | CA$10.15 Million | +1633.08% |
| 2017-12-31 | CA$-661.78K | -239.86% |
| 2016-12-31 | CA$473.17K | +32.64% |
| 2015-12-31 | CA$356.72K | -29.03% |
| 2014-12-31 | CA$502.65K | -6.66% |
| 2013-12-31 | CA$538.51K | +228.72% |
| 2012-12-31 | CA$163.82K | -10.64% |
| 2011-12-31 | CA$183.34K | -- |
Equity Component Analysis
This analysis shows how different components contribute to WELL Health Technologies Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3097331000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | CA$784.87 Million | 90.46% |
| Other Comprehensive Income | CA$67.09 Million | 7.73% |
| Other Components | CA$46.62 Million | 5.37% |
| Total Equity | CA$867.61 Million | 100.00% |
WELL Health Technologies Corp Competitors by Market Cap
The table below lists competitors of WELL Health Technologies Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Sanhe Tongfei Refrigeration Co. Ltd.
SHE:300990
|
$576.46 Million |
|
Phreesia Inc
NYSE:PHR
|
$576.65 Million |
|
People & Technology Inc
KQ:137400
|
$576.76 Million |
|
SkyCity Entertainment Group Limited
PINK:SKYZF
|
$576.82 Million |
|
Rai Way SpA
LSE:0R40
|
$576.21 Million |
|
MoonLake Immunotherapeutics
NASDAQ:MLTX
|
$575.79 Million |
|
Xi'an Manareco New Materials Co.Ltd
SHG:688550
|
$575.54 Million |
|
Start Group
SHG:600734
|
$575.42 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in WELL Health Technologies Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 767,666,000 to 867,607,000, a change of 99,941,000 (13.0%).
- Net income of 32,609,000 contributed positively to equity growth.
- Share repurchases of 1,658,000 reduced equity.
- New share issuances of 47,645,000 increased equity.
- Other comprehensive income increased equity by 41,436,000.
- Other factors decreased equity by 20,091,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CA$32.61 Million | +3.76% |
| Share Repurchases | CA$1.66 Million | -0.19% |
| Share Issuances | CA$47.65 Million | +5.49% |
| Other Comprehensive Income | CA$41.44 Million | +4.78% |
| Other Changes | CA$-20.09 Million | -2.32% |
| Total Change | CA$- | 13.02% |
Book Value vs Market Value Analysis
This analysis compares WELL Health Technologies Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.24x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 118.71x to 1.24x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | CA$0.04 | CA$4.21 | x |
| 2013-12-31 | CA$0.10 | CA$4.21 | x |
| 2014-12-31 | CA$0.08 | CA$4.21 | x |
| 2015-12-31 | CA$0.05 | CA$4.21 | x |
| 2016-12-31 | CA$0.05 | CA$4.21 | x |
| 2017-12-31 | CA$-0.02 | CA$4.21 | x |
| 2018-12-31 | CA$0.15 | CA$4.21 | x |
| 2019-12-31 | CA$0.33 | CA$4.21 | x |
| 2020-12-31 | CA$1.62 | CA$4.21 | x |
| 2021-12-31 | CA$3.24 | CA$4.21 | x |
| 2022-12-31 | CA$3.32 | CA$4.21 | x |
| 2023-12-31 | CA$3.25 | CA$4.21 | x |
| 2024-12-31 | CA$3.41 | CA$4.21 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently WELL Health Technologies Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 3.76%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.55%
- • Asset Turnover: 0.51x
- • Equity Multiplier: 2.08x
- Recent ROE (3.76%) is above the historical average (-20.78%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | -32.05% | 0.00% | 0.00x | 1.21x | CA$-68.89K |
| 2013 | -22.02% | 0.00% | 0.00x | 1.03x | CA$-172.44K |
| 2014 | -7.13% | 0.00% | 0.00x | 1.04x | CA$-86.13K |
| 2015 | -40.91% | -35.54% | 1.06x | 1.08x | CA$-181.60K |
| 2016 | -123.72% | -205.68% | 0.30x | 2.00x | CA$-632.71K |
| 2017 | 0.00% | -2459.17% | 0.94x | 0.00x | CA$-10.14 Million |
| 2018 | -20.14% | -34.65% | 0.46x | 1.26x | CA$-3.06 Million |
| 2019 | -24.38% | -23.75% | 0.56x | 1.83x | CA$-10.99 Million |
| 2020 | -1.21% | -5.22% | 0.19x | 1.21x | CA$-24.36 Million |
| 2021 | -4.96% | -10.15% | 0.24x | 2.04x | CA$-92.51 Million |
| 2022 | 2.60% | 3.35% | 0.43x | 1.80x | CA$-54.16 Million |
| 2023 | 0.01% | 0.01% | 0.55x | 1.84x | CA$-76.68 Million |
| 2024 | 3.76% | 3.55% | 0.51x | 2.08x | CA$-54.15 Million |
Industry Comparison
This section compares WELL Health Technologies Corp's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $6,227,214
- Average return on equity (ROE) among peers: 2.74%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| WELL Health Technologies Corp (WELL) | CA$844.39 Million | -32.05% | 1.39x | $576.26 Million |
| Element Lifestyle Retirement Inc (ELM) | $-590.09K | 0.00% | 0.00x | $306.54K |
| KDA Group Inc (KDA) | $3.91 Million | 14.35% | 4.67x | $12.36 Million |
| NeuPath Health Inc (NPTH) | $21.43 Million | -3.40% | 0.93x | $16.35 Million |
| Premier Health of America Inc (PHA) | $154.00K | 0.00% | 0.28x | $459.41K |